Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05254574
PHASE1

Sustained Acoustic Medicine for Osteoarthritis Pain

Sponsor: ZetrOZ, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.

Key Details

Gender

All

Age Range

35 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2022-02-14

Completion Date

2026-05-31

Last Updated

2025-02-27

Healthy Volunteers

Yes

Conditions

Interventions

DEVICE

Sustained Acoustic Device with 2.5% Diclofenac Patch

Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm@ with 2.5% Diclofenac patches.

DRUG

2.5% Diclofenac Patches

Topical pain relief-gel worn for 4 hours at least 5 days a week via SAM patch.

Locations (1)

James A Haley Veterans Hospital

Tampa, Florida, United States